BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 1223898)

  • 1. Role of dopamine in d-amphetamine-induced discriminative responding.
    Ho BT; Huang JT
    Pharmacol Biochem Behav; 1975; 3(6):1085-92. PubMed ID: 1223898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CGS 10746B is able to attenuate the effects of amphetamine: further evidence for dopaminergic mediation.
    Schechter MD; Boja JW
    Pharmacol Biochem Behav; 1988 Aug; 30(4):1089-92. PubMed ID: 2906435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of blockade of central dopaminergic receptors by narcotics: comparison with chlorpromazine.
    Schechter MD
    Eur J Pharmacol; 1978 Jun; 49(3):279-84. PubMed ID: 658141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of opiates on the discriminative stimulus properties of dopamine agonists.
    Hernandez LL; Holohean AM; Appel JB
    Pharmacol Biochem Behav; 1978 Oct; 9(4):459-63. PubMed ID: 733832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of d-amphetamine on temporal and spatial discrimination in rats.
    Sanger DJ
    Psychopharmacology (Berl); 1978 Jul; 58(2):185-8. PubMed ID: 98789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (-)-Nornicotine partially substitutes for (+)-amphetamine in a drug discrimination paradigm in rats.
    Bardo MT; Bevins RA; Klebaur JE; Crooks PA; Dwoskin LP
    Pharmacol Biochem Behav; 1997 Dec; 58(4):1083-7. PubMed ID: 9408217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of dopamine D1 and D2 receptors in mediating the d-amphetamine discriminative cue.
    Furmidge LJ; Exner M; Clark D
    Eur J Pharmacol; 1991 Sep; 202(2):191-9. PubMed ID: 1687032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. D-amphetamine-like stimulus properties are produced by morphine injections into the ventral tegmental area but not into the nucleus accumbens.
    Druhan JP; Deschamps SE; Stewart J
    Behav Brain Res; 1993 Dec; 59(1-2):41-51. PubMed ID: 8155292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The dopamine D3 receptor antagonist PNU-99194A fails to block (+)-7-OH-DPAT substitution for D-amphetamine or cocaine.
    Baker LE; Svensson KA; Garner KJ; Goodwin AK
    Eur J Pharmacol; 1998 Oct; 358(2):101-9. PubMed ID: 9808258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioural effects of the alpha 2-adrenoceptor antagonists idazoxan and yohimbine in rats: comparisons with amphetamine.
    Sanger DJ
    Psychopharmacology (Berl); 1988; 96(2):243-9. PubMed ID: 2906748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amphetamine discrimination as a test for anti-parkinsonism drugs.
    Schechter MD
    Eur J Pharmacol; 1977 Jul; 44(1):51-6. PubMed ID: 885158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the dopamine autoreceptor antagonist (-)-DS121 on the discriminative stimulus properties of d-amphetamine and cocaine.
    Clark D; Exner M; Furmidge LJ; Svensson K; Sonesson C
    Eur J Pharmacol; 1995 Feb; 275(1):67-74. PubMed ID: 7774664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid-dopaminergic mechanisms in the potentiation of d-amphetamine discrimination by interferon-alpha.
    Ho BT; Huo YY; Lu JG; Tansey LW; Levin VA
    Pharmacol Biochem Behav; 1992 May; 42(1):57-60. PubMed ID: 1528947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of non-contingent amphetamine injections on the extinction of food- and drug-reinforced lever pressing in rats.
    Lindquist M; Andersson BE; Götestam KG
    Addict Behav; 1977; 2(4):167-79. PubMed ID: 607788
    [No Abstract]   [Full Text] [Related]  

  • 15. Acute effects of d-amphetamine on the differential reinforcement of low-rate (DRL) schedule behavior in the rat: comparison with selective dopamine receptor antagonists.
    Liao RM; Cheng RK
    Chin J Physiol; 2005 Mar; 48(1):41-50. PubMed ID: 15973966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid acquisition of a two-drug discrimination: time of day effect upon saline state.
    Schechter MD
    Pharmacol Biochem Behav; 1981 Mar; 14(3):269-71. PubMed ID: 7232454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine receptor antagonists reverse amphetamine-induced behavioral alteration on a differential reinforcement for low-rate (DRL) operant task in the rat.
    Cheng RK; Liao RM
    Chin J Physiol; 2007 Apr; 50(2):77-88. PubMed ID: 17608145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of d-amphetamine and apomorphine upon operant behavior and schedule-induced licking in rats with 6-hydroxydopamine-induced lesions of the nucleus accumbens.
    Robbins TW; Roberts DC; Koob GF
    J Pharmacol Exp Ther; 1983 Mar; 224(3):662-73. PubMed ID: 6402587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 5-HT3 receptor partial agonist MD-354 (meta-chlorophenylguanidine) enhances the discriminative stimulus actions of (+)amphetamine in rats.
    Dukat M; Wesolowska A; Young R; Glennon RA
    Pharmacol Biochem Behav; 2007; 87(2):203-7. PubMed ID: 17540440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal parameters of d-amphetamine as a discriminative stimulus in the rat.
    Jones CN; Grant LD; Vospalek DM
    Psychopharmacologia; 1976; 46(1):59-64. PubMed ID: 1257368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.